Medications for pulmonary embolism may decrease the size of blood clots, help dissolve them, or reduce the risk of recurrence. All of these medications carry the risk of bleeding. A pulmonary ...
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
Shatti, head of the Cardiac Catheterization Unit at Al-Dabous Center at Al-Adan Hospital, announced that the hospital has ...
8don MSN
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...
According to a GoFundMe account for the family, 17-year-old Finley Kruchten suffered a cardiac arrest due to a massive pulmonary embolism on the morning of Oct. 1. The incident reportedly began in ...
(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.
The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.
Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback